BOLI de Colagen
-
Upload
danaogreanu -
Category
Documents
-
view
308 -
download
3
Transcript of BOLI de Colagen
![Page 1: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/1.jpg)
BOLI DE COLAGEN
SCLERODERMIA
![Page 2: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/2.jpg)
SCLERODERMIA
• Sinonime : scleroza sistemica (SS)• Definitie : boala generalizata a
tesutului conjuctiv caracterizata clinic prin :– Ingrosarea si fibroza pielii
(SCLERODERMA: scleros = dur, derma = piele)
– Afectarea organelor interne : inima, plaman, rinichi, tract gastro-intestinal
![Page 3: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/3.jpg)
SCLERODERMIA
• Epidemiologie : – Incidenta : 18 – 20 pacienti /milion/an– Prevalenta : 100000 cazuri in USA– Varsta debutului : 30-50 ani, dar
poate debuta la orice varsta– F/B : 3-4/1
![Page 4: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/4.jpg)
SCLERODERMIA
• Etiologie : necunoscuta• Factorii de risc :
– Genetici : • RR al rudelor de gradul I crescut pentru
SS (RR =13) sau alte boli autoimune (LES,PR)
• Asociere slaba cu genele HLA
– Factorii de mediu
![Page 5: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/5.jpg)
Kelley’s textbook of rheumatologyKelley’s textbook of rheumatology
![Page 6: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/6.jpg)
SCLERODERMIA
• Etiologie : necunoscuta• Factorii de risc :
– Factorii de mediu :• Infectiosi : CMV• Noninfectiosi : produse petroliere (toluen,
tricloretilen), clorura de polivinil , L-triptofan, silicon, medicamente ( bleomicina, pentazocina, cocaina, unele anorexigene
![Page 7: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/7.jpg)
SCLERODERMIA
• Patogenie : trei procese patogenice esentiale (1) activarea SI prin inflamatie
(prezenta in fazele precoce ale bolii) si autoimunitate (2) vasculopatia obliterativa
(3) fibroza progresiva viscerala si vasculara in multiple organe
![Page 8: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/8.jpg)
SCLERODERMIA
• Patogenie : mecanisme autoimune
– Susceptibilitate genetica : asocierea cu alte boli autoimune la acelasi individ (sindrom overlap) sau la rudele sale
– Prezenta autoanticorpilor : anti-topoizomeraza (proteina implicata in mitoza), anti- proteine centromerice, ANA (>95%)
– Asocierea autoanticorpilor cu moleculele HLA-DQ sintetizate de gene ale raspunsului imun
![Page 9: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/9.jpg)
SCLERODERMIA
• Patogenie : inflamatie si autoimunitate
– Afectarea /lezarea endoteliului vascular este momentul initial in patogeneza SS
– Factorii trigger posibili : factori serici citotoxici (radicalii de oxigen?), enzime proteolitice (?), autoanticorpi anti celula endoteliala (?),virusuri vasculotrope (?), citokinele inflamatorii (?), factorii de mediu (?)
![Page 10: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/10.jpg)
SCLERODERMIA
• Patogenie : activarea sistemului imun
– Limfocitele T: infiltrate limfocitare perivasculare in fazele precoce ale bolii (CD4 in piele, CD8 in plaman)
• Prezenta infiltratelor cu celule T cu profil secretor de tip TH2 si actiune profibrotica: IL4, IL5 , IL13, IL6
– Activarea monocitelo/macrofagelor cu secretia de citokine proinflamatorii (IL1,TNFalfa) si profibrotice ( IL6, TGF-beta)
– Limfocitele B :• Productie de autoanticorpi, IL6
![Page 11: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/11.jpg)
SCLERODERMIA
• Patogenie : vasculopatia proliferativ/obliterativa
• Cresterea reactivitatii vasculare prin injuria endoteliului vascular cu dereglarea productiei de substante vasodilatatoare (prostaciclina, oxidul nitric) si vasoconstrictoare (endotelina-1)
• Agregare plachetara : tromboze intravasculare , eliberare de substante vasoconstrictoare (tromboxan)
• Remodelare vasculara : proliferarea intimei si a mediei, fibroza adventicei
![Page 12: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/12.jpg)
SCLERODERMIA
• Patogenie : vasculopatia
– Ingustarea lumenului vascular :• Vasoconstrictie, ischemie de reperfuzie• Remodelare vasculara : proliferarea
intimei, fibroza adventicei• Tromboze intravasculare
– Obliterare vasculara si hipoxie tisulara
![Page 13: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/13.jpg)
SCLERODERMIA
• Endotelina -1 eliberata de celulele endoteliale activate :– cel mai puternic vasoconstrictor– promoveaza adeziunea leucocitelor si
proliferarea celulelor musculaturii netede vasculare
– activarea fibroblastilor
![Page 14: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/14.jpg)
SCLERODERMIA
• Patogenie :– Fibroza : rezultatul final al inflamatiei
cronice, autoimunitatii, afectarii vasculare si a hipoxiei. Este caracterizata prin :
• Inlocuirea tesutului normal cu tesut conjuctiv dens
• Activarea si proliferarea unui fenotip anormal de fibroblasti (“fenotip sclerodermic”), caracterizat prin cresterea persistenta a sintezei de colagen si a matricei extracelulare, secretia de citokine profibrotice si rezistenta la semnale inhibitorii (ex. ITF gama)
![Page 15: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/15.jpg)
SCLERODERMIA
• Morfopatologie : – leziunile morfopatologice sunt prezente
in:• Piele• Tractul GI : gura, esofag, stomac, intestin• Plaman • Rinichi • Inima • Alte organe :sinoviala, tecile tendoanelor,
muschi, glanda tiroida, glandele salivare
![Page 16: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/16.jpg)
SCLERODERMIA
• Morfopatologie : leziunile morfopatologice caracteristice sunt :
– Vasculopatie obliterativa a arterelor mici si a arteriolelor caracterizata prin proliferarea intimei si ingustarea lumenului: inima, plamanul, rinichii, tractul intestinal
– Fibroza interstitiala a organelor tinta : piele, plaman, tract gastrointestinal, inima, teaca tendoanelor, tesutul perifascicular al muschilor scheletici, unele organe endocrine (tiroida) care are drept consecinta
• Inlocuirea parenchimului cu un tesut conjuctiv omogen, distrugerea arhitecturii, disfunctiionalitate, insuficienta de organ
![Page 17: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/17.jpg)
SCLERODERMIA
• Patogenie :– Manifestari ale vasculopatiei vaselor
mici :• Sindromul Raynau • Telangiectasia • Hipertensiunea arteriala pulmonara• Criza renala sclerodermica
![Page 18: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/18.jpg)
SCLERODERMIA
• Patogenie :– Manifestari ale procesului de
fibroza :•Ingrosarea pielii•Boala pulmonara parenchimatoasa•Dismotilitatea tractului
gastrointestinal
![Page 19: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/19.jpg)
SCLERODERMIA
• Clasificare :– Sclerodermia localizata
• Morpheea• Lineara • In “lovitura de sabie”
– Scleroza sistemica• Localizata : boala cutanata limitata (distal
de coate si /sau genunchi)• Difuza : boala cutanata difuza
![Page 20: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/20.jpg)
SCLERODERMIA
• Manifestari clinice la debut :– Sindromul Raynaud (mai ales in
formele cutanate limitate)– Tumefierea difuza a mainilor,
ingrosarea tegumentelor sau artrita in formele de boala cu afectare difuza
– Ocazional , afectarea viscerala : simptome esofagiene (disfagie, pirozis) sau pulmonare (dispnee)
![Page 21: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/21.jpg)
SCLERODERMIA
• Manifestari clinice :– Sindromul Raynaud secundar SS :
• Vasculopatie obliterativa a vaselor mici ale membrelor + vasospasm indus de frig
• Principala forma de debut in SS localizata (poate precede celelalte simptome/semne cu luni sau ani)
• Evolutie fazica : paloare (vasospasm), cianoza (staza venoasa), roseata (hiperemia si revenirea fluxului sanguin)
• Leziuni ireversibile : ulcere digitale, suprafetele de extensie a IPP, MCP, stiloida ulnara, cot (ischemie + microtrumatism), gangrena (nu sunt prezente in sindromul Raynaud primar)
• Poate precede alte manifestari clinice cu luni sau ani
![Page 22: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/22.jpg)
SCLERODERMIA
• Manifestari clinice : modificari ale pielii ( ingrosarea tegumentelor)– edeme cu sau fara godeu ale degetelor, mainilor,
antebratelor, fetei, gambe, picioare (faza edematoasa)
– piele ingrosata si dura la degete, maini, fata +/- antebrate, brate, piept, membre inferioare, abdomen (faza indurativa)
– telangiectazii (dilatatia vaselor din derm) – calcinoza (calcificari cutanate sau subcutanate din
hidroxiapatita)– cicatrici ale pulpei degetelor, ulceratii, gangrene,
mumificare, amputare
![Page 23: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/23.jpg)
SCLERODERMIA• Manifestari clinice : tractul gastrointestinal (prin
dismotilitate determinata de atrofia si fibroza musculaturii netede sau vasculopatie/GAVE : gastric antral vascular ectasia)
– Gura : ingrosarea tegumentului perioral, reducerea aperturii orale, carii dentare xerostomia
– Esofag : reflux, stricturi, metaplazia Barrett– Stomac : gastropareza (satietate precoce), gastrita, ectazii
vasculare antrale– Intestinul subtire : hipomotilitate (borborigme, flatulenta),
staza, suprapopulare bacteriana (diaree, malabsorbtie), pseudo-obstructie, pneumomatoza
– Colonul : hipomotilitate, pseudo-obstructie, pseudo-diverticuli– Anus si rect : incompetenta sfincteriana– Ficat : ciroza biliara primitiva
![Page 24: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/24.jpg)
SCLERODERMIA
• Manifestari clinice pulmonare :
– Fibroza pulmonara : dispnee, tuse seaca, modificari Rx, disfunctie ventilatorie restrictiva, HRCT(85% din pacientii cu SS), DLCO, lavajul bronhoalveolar
– Hipertensiunea pulmonara:DLCO (scadere izolata), ECO, cateterismul cordului drept
• Prin afectare:– pulmonara : fibroza, vasculopatie sclerodermica– cardiaca : disfunctie diastolica, boala valvulara, ICC
![Page 25: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/25.jpg)
• Manifestari
![Page 26: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/26.jpg)
• Anti Topoisomerase-I : SS difuza, fibroza pulmonara, afectarea cardiaca, criza renala sclerodermica
• Anti proteine ale centromerului :SS localizata, ischemia degetelor, calcinoza, HTP izolata
• U3-RNP : dcSScPAH, ILD, scleroderma renal crisis, myositis
• Th/T0 : lcSScILD, PAH• PM/Scl : lcSScCalcinosis, myositis• U1-RNP : MCTD, PAH• RNA polymerase III : dcSScExtensive skin, scleroderm
![Page 27: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/27.jpg)
Scleroderma: Raynaud’s phenomenon, blanching of hands
![Page 28: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/28.jpg)
Scleroderma: Raynaud’s phenomenon, cyanosis of the hands
![Page 29: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/29.jpg)
![Page 30: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/30.jpg)
Scleroderma: edematous changes, hands
![Page 31: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/31.jpg)
Scleroderma: skin induration, hands
![Page 32: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/32.jpg)
Scleroderma: acrosclerosis and terminal digit resorption
![Page 33: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/33.jpg)
CREST syndrome: calcinosis cutis, fingers
![Page 34: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/34.jpg)
Scleroderma: Mauskopf, facial changes
![Page 35: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/35.jpg)
Scleroderma: Mauskopf, facial changes
![Page 36: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/36.jpg)
Linear scleroderma: thigh and leg
![Page 37: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/37.jpg)
Morphea: leg
![Page 38: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/38.jpg)
Eosinophilic fasciitis: cutaneous lesions, arm
![Page 39: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/39.jpg)
Scleroderma: acrolysis (radiographs)
![Page 40: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/40.jpg)
Scleroderma: calcinosis and acrolysis (radiograph)
![Page 41: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/41.jpg)
Scleroderma: pulmonary fibrosis (radiograph)
![Page 42: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/42.jpg)
Isenberg DA, Renton P, Imaging in Rheumatology, 2003Isenberg DA, Renton P, Imaging in Rheumatology, 2003
FIBROZA PULMONARA FIBROZA PULMONARA >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
![Page 43: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/43.jpg)
Isenberg DA, Renton P, Imaging in Rheumatology, 2003Isenberg DA, Renton P, Imaging in Rheumatology, 2003
![Page 44: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/44.jpg)
Scleroderma: abnormal motility, esophagus (radiograph)
Isenberg DA, Renton P, Imaging in Rheumatology, 2003Isenberg DA, Renton P, Imaging in Rheumatology, 2003
![Page 45: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/45.jpg)
Scleroderma: wide-mouthed diverticula, colon (radiograph)
![Page 46: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/46.jpg)
• DISEASE CLASSIFICATION — Five major diffuse connective tissue diseases (DCTD) exist according to current classification schema: systemic lupus erythematosus (SLE); scleroderma (Scl); polymyositis (PM); dermatomyositis (DM); and rheumatoid arthritis (RA). A sixth disorder, Sjögren's syndrome, is commonly associated with each of these diseases, but is called primary Sjögren's syndrome when it occurs alone.
• The classical clinical descriptions of these disorders are well known and most patients with well-differentiated disease are easily recognized. However, experienced physicians often note that one DCTD seems to evolve into another over the course of several years [5-10] . This occurs in about 25 percent of patients, who are then said to have an overlap syndrome [6] . (See "Undifferentiated systemic rheumatic (connective tissue) diseases and overlap syndromes").
• (Definition and diagnosis of mixed connective tissue disease )
![Page 47: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/47.jpg)
• Is MCTD a specific disease? — If a distinct illness requires both unique clinical features and consistent pathology, then none of the DCTDs can be defined as a specific illness. Each DCTD contains subsets of patients with clinical and pathologic characteristics which differ from other patients with the same diagnosis.
• In the early stages most patients destined to develop MCTD cannot be differentiated from the other classical DCTDs. The early simultaneous presence of overlap features usually seen in SLE, Scl and PM is seldom seen. More commonly the overlapping features occur sequentially over several years. Prominent early symptoms are: easy fatiguability poorly defined myalgias, arthralgias and Raynaud phenomenon. The common diagnostic considerations at this juncture are usually RA, SLE or undifferentiated connective tissue disease (UCTD) [7,8] . A patient with swollen hands and/or puffy fingers in association with a high titer speckled ANA should be carefully followed for the evolution of overlap features. A high titer of anti-RNP antibodies in such a patient is a powerful predictor of a later evolution into MCTD [9,10] . Other, less common, early features include: a severe inflammatory myopathy, acute arthritis, aseptic meningitis, digital gangrene, high fever, acute abdomen and trigeminal neuropathy.
![Page 48: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/48.jpg)
• The major reason to consider MCTD a distinct clinical entity is that the presence of high titers of anti-U1 RNP antibodies is associated with several distinctive clinical characteristics; for example:
• Patients with U1 RNP antibodies seldom develop diffuse proliferative glomerulonephritis, psychosis, or seizures; these abnormalities are a major source of morbidity and mortality in SLE [11,12] .
• Patients with U1 RNP antibodies nearly always have an early development of Raynaud phenomenon [1,2] and a nailfold capillary pattern that is the same as in Scl but different from classical SLE [13] . The Raynaud phenomenon only occurs in about 25 percent of patients with classical SLE.
• Patients with U1 RNP antibodies are more likely to develop pulmonary hypertension than patients with classical SLE or Scl. Pulmonary hypertension is the major cause of death in MCTD [14,15] .
• Patients with U1 RNP antibodies are more likely than SLE patients to be rheumatoid factor positive [2] and develop an erosive arthritis [3,16] .
• Thus, the concept of MCTD is useful in defining a subgroup of patients with unique clinical features, treatment profile, and prognosis. Whether MCTD is a unique subset of SLE or Scl or is a distinct clinical entity is not clinically so important.
![Page 49: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/49.jpg)
• The criteria utilized by Alarcon-Segovia had a sensitivity and specificity of 63 and 86 percent and is the most widely used.
• These classification criteria are as follows [19] :• Serologic criteria — Anti-RNP antibodies at a hemagglutination titer
> 1:1600• Clinical criteria — Swollen hands, synovitis, biologically or
histologically proven myositis, Raynaud phenomenon, and acrosclerosis with or without proximal systemic sclerosis – If serologic criteria and at least three of the five clinical criteria are
present then a diagnosis of MCTD can be made. – However, a patient with sufficiently elevated anti-RNP titers in
combination with swollen hands, Raynaud phenomenon, and acrosclerosis with or without proximal systemic sclerosis, must also have either synovitis or myositis to meet the criteria for diagnosis
![Page 50: BOLI de Colagen](https://reader033.fdocuments.net/reader033/viewer/2022051211/55258ebb550346a26e8b496e/html5/thumbnails/50.jpg)
• CLINICAL MANIFESTATIONS — The early clinical features of MCTD are nonspecific and may consist of general malaise, arthralgias, myalgias, and low-grade fever [2,5] . A specific clue that these symptoms are caused by a connective tissue disease is the discovery of a positive antinuclear antibody (ANA) in association with Raynaud's phenomenon [6] .
• As will be described below, almost any organ system can be involved in MCTD. There are, however, four clinical features that suggest the presence of MCTD rather than another connective tissue disorder such as SLE or Scl:
• Raynaud's phenomenon and swollen hands or puffy fingers [7,8] • The absence of severe renal and central nervous system (CNS) disease
[2,9,10] • More severe arthritis and the insidious onset of pulmonary hypertension (not
related to lung fibrosis) differentiate MCTD from both SLE and Scl [11,12] • Autoantibodies whose fine specificity is anti-U1 RNP, especially antibodies to
the 68 Kd protein [13] ( Clinical manifestations of mixed connective tissue disease )